about
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitorsInjectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)Using the Ferret as an Animal Model for Investigating Influenza Antiviral EffectivenessA novel video tracking method to evaluate the effect of influenza infection and antiviral treatment on ferret activityA mathematical framework for estimating pathogen transmission fitness and inoculum size using data from a competitive mixtures animal modelEstimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza virusesMolecular surveillance of antiviral drug resistance of influenza A/H3N2 virus in Singapore, 2009-2013Epidemiological and virological characteristics of influenza viruses circulating in Cambodia from 2009 to 2011Oseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza VirusesReducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context.Seasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region.Continued dominance of pandemic A(H1N1) 2009 influenza in Victoria, Australia in 2010Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.Performance of six influenza rapid tests in detecting human influenza in clinical specimens.Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact.Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical managementCombined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity.Quantifying relative within-host replication fitness in influenza virus competition experiments.Zanamivir-resistant influenza viruses with a novel neuraminidase mutationDetection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir using rolling circle amplification.Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses.Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case.Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza.Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia.The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay.Influenza antivirals currently in late-phase clinical trial.Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.A comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1) 2009 viruses.Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals.Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives.Mutations I117V and I117M and oseltamivir sensitivity of pandemic (H1N1) 2009 viruses.Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination.The chemiluminescent neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors.The fluorescence neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors.Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011.Influenza antiviral resistance in the Asia-Pacific region during 2011.Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model.Seroprevalence of seasonal and pandemic influenza a in Kuala Lumpur, Malaysia in 2008-2010.Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.Detection of evolutionarily distinct avian influenza a viruses in antarctica
P50
Q22305941-90FD6E22-1BFA-4E89-B698-0B7541970337Q24645944-748E1073-7D78-43CF-A53A-4AA18A2F50D2Q27000668-46416D31-CCDB-4F42-9E61-A1900FFA7209Q27312788-D02DDAA5-5A44-4C7D-8451-448E08A0434CQ28477927-FD2939B1-E74B-408D-84A3-0AF0439048AEQ28541953-9E94BFCC-B1E1-4C86-959D-6B56135A630BQ28543158-4143A3FE-B693-403C-8B62-DEB7741AFDFBQ28544035-171AD785-D266-446A-9DD2-C6413EBD3E7AQ28548477-E9A9F7DA-98BE-4678-9EF4-4DAA43E56EF2Q30151721-DFE5AE05-EEC9-4EF2-AFE3-726CB105C393Q30218410-5CD00282-00CE-4C46-B382-8D6A0A62BDEBQ30352552-B0C8E518-578C-45EF-9415-2840CFB5F3C3Q30356751-9743DDC6-9430-4BB4-BB76-D04EDC7522DBQ30361246-AF3604C3-6A91-4227-86B1-810A7261C4E8Q30362700-170F0D0F-F13C-48E8-9657-20DCF29FBED7Q30368680-B84D8511-B853-4301-BE85-5F8A0315D5E6Q30374900-42A11E13-AF1B-4A1A-A9D3-2E445BD74E1DQ30376871-4F780521-8B25-48A1-B4A7-4A8A9D46D0B8Q30379353-F4880D1D-1B11-430F-9784-CE14326E8777Q30381305-6E3C211F-A52D-41FD-BF3B-BF1613A17605Q30382944-5F3858B8-F998-49AD-A6D9-B4D2F763D3FEQ30385172-CE0B8F90-DCE7-419F-8869-5D5270E612EFQ30388177-0BEB7B72-18CE-48D4-B16D-FA35DF41532EQ30390856-80E271F6-4DED-4F09-BAE1-188E012C6073Q30391063-681B3722-8E2B-4396-94D7-0862B58FB1C5Q30398099-1FBFD267-46C0-4315-9C98-495146C5E9A5Q30398923-67DA498B-6D28-4A53-B5E1-68C9456E2844Q30400439-6EA41E66-ED4C-4CEE-BF7D-9CF2070E14CBQ30401424-60D19CB6-2F82-48E8-9D37-E54ABA3A1B30Q30410899-7B8BFCA7-FF95-4773-9090-F2DA3EFAEDF2Q30411999-86DF0F94-58F2-4121-934D-1B5C88785D92Q30415267-05F3907F-942A-490A-9A91-17061B0C8390Q30415934-0C57C4F6-114C-404E-81EF-983A196E79A9Q30415937-BA958CEA-D2DD-45D6-B8BF-23D1D676EEEBQ30419130-3551ED4C-E6DE-4868-8FC3-CFA69A869862Q30425223-F4EB6BEB-CE9F-4B94-9F1C-BC4EE8D6A667Q30430458-25BA02CA-18F7-465C-A286-0B6185674F9CQ30431906-84192165-B5DB-4B13-8591-499D1C4ECDCBQ33263979-E323AABF-5464-4C24-92D8-B0E77F1FC005Q33569528-A7A809CE-123B-4E37-B231-06AED8A1939C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Aeron C. Hurt
@ast
Aeron C. Hurt
@en
Aeron C. Hurt
@es
Aeron C. Hurt
@nl
type
label
Aeron C. Hurt
@ast
Aeron C. Hurt
@en
Aeron C. Hurt
@es
Aeron C. Hurt
@nl
prefLabel
Aeron C. Hurt
@ast
Aeron C. Hurt
@en
Aeron C. Hurt
@es
Aeron C. Hurt
@nl
P106
P1153
6603378203
P21
P31
P496
0000-0003-1826-4314